Mohamad Hussein

Dr. Mohamad Hussein, MD, currently severs as a Professor of Medicine and Oncology at the University of South Florida College of Medicine.

With over 30 years of combined academia and pharmaceutical experience in hematologic malignancies, cell therapy, hematology and oncology, Dr. Hussein is considered a global leader. He has been published over 100 times, and served as the Editor in Chief (International Journal of Surgical Oncology), a review member (Lancet, Medical Science Monitor, International Medical Journal for Experimental and Clinical Research, CME American Society of Clinical Oncology, and Panasonic Laptop Development) and consultant to the scientific journal community. His vast involvement with clinical trials and funded research spans across the nation.

Dr. Hussein served on 6 committees at H Lee Moffitt Cancer and Research Center between 2006-2008, as well as 5 committees at Cleveland Clinic (1991-2006), and 22 additional external committees and advisory boards throughout his career. As a Medical Affairs leader, Dr. Hussein left a significant footprint from his tenure at Celgene. His accomplishments include building a robust Medical Affairs division, creating a Global Hematology physician group, driving the pipeline strategy for multiple myeloma, and life cycle management.